Next Article in Journal
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival
Next Article in Special Issue
Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma
Previous Article in Journal / Special Issue
Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Cancers 2019, 11(1), 123; https://doi.org/10.3390/cancers11010123

PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP

1
Team Récepteurs, Régulations, Cellules Tumorales (2RCT), EA3842 CAPTuR, Pôle Biologie-Santé, Université de Poitiers, F-86022 Poitiers, France
2
STIM Laboratory, CNRS ERL 7003-EA7349, Pôle Biologie-Santé, Université de Poitiers, F-86022 Poitiers, France
3
Laboratoire de Neurosciences Expérimentales et Cliniques (LNEC)–INSERM UMR-S1084, Pôle Biologie-Santé, Université de Poitiers, F-86022 Poitiers, France
*
Author to whom correspondence should be addressed.
Received: 19 December 2018 / Revised: 8 January 2019 / Accepted: 10 January 2019 / Published: 21 January 2019
(This article belongs to the Special Issue Glioblastoma: State of the Art and Future Perspectives)
Full-Text   |   PDF [3257 KB, uploaded 21 January 2019]   |  
  |   Review Reports

Abstract

Glioblastoma (GBM) remains an incurable disease, mainly due to the high migration and invasion potency of GBM cells inside the brain. PI3K/Akt, Sonic Hedgehog (SHH), and PKA pathways play major regulatory roles in the progression of GBM. The vasoactive intestinal peptide (VIP) family of neuropeptides and their receptors, referred in this article as the “VIP-receptor system”, has been reported to regulate proliferation, differentiation, and migration in a number of tumor cell types and more particularly in GBM cells. These neuropeptides are potent activators of the cAMP/PKA pathway. The present study aimed to investigate the cross-talks between the above cited signaling cascades. Regulation by VIP-related neuropeptides of GBM migration and invasion was evaluated ex vivo in rat brain slices explanted in culture. Effects of different combinations of VIP-related neuropeptides and of pharmacological and siRNA inhibitors of PKA, Akt, and of the SHH/GLI1 pathways were tested on GBM migration rat C6 and human U87 GBM cell lines using the wound-healing technique. Quantification of nuclear GLI1, phospho-Akt, and phospho-PTEN was assessed by western-immunoblotting. The VIP-receptor system agonists VIP and PACAP-38 significantly reduced C6 cells invasion in the rat brain parenchyma ex vivo, and C6 and U87 migration in vitro. A VIP-receptor system antagonist, VIP10-28 increased C6 cell invasion in the rat brain parenchyma ex vivo, and C6 and migration in vitro. These effects on cell migration were abolished by selective inhibitors of the PI3K/Akt and of the SHH pathways. Furthermore, VIP and PACAP-38 reduced the expression of nuclear GLI1 while VIP10-28 increased this expression. Selective inhibitors of Akt and PKA abolished VIP, PACAP-38, and VIP10-28 effects on nuclear GLI1 expression in C6 cells. PACAP-38 induced a time-dependent inhibition of phospho-Akt expression and an increased phosphorylation of PTEN in C6 cells. All together, these data indicate that triggering the VIP-receptor system reduces migration and invasion in GBM cells through a PKA-dependent blockade of the PI3K/Akt and of the SHH/GLI1 pathways. Therefore, the VIP-receptor system displays anti-oncogenic properties in GBM cells and PKA is a central core in this process. View Full-Text
Keywords: glioblastoma; protein kinase A; Sonic Hedgehog; Akt; PTEN; VIP-receptor system glioblastoma; protein kinase A; Sonic Hedgehog; Akt; PTEN; VIP-receptor system
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Bensalma, S.; Turpault, S.; Balandre, A.-C.; De Boisvilliers, M.; Gaillard, A.; Chadéneau, C.; Muller, J.-M. PKA at a Cross-Road of Signaling Pathways Involved in the Regulation of Glioblastoma Migration and Invasion by the Neuropeptides VIP and PACAP. Cancers 2019, 11, 123.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top